On October 22, Nobel Prize–winning biochemist Dr. Jennifer Doudna dined with supporters of UCSB Arts & Lectures (A&L) and the Cancer Foundation of S.B. (CFSB). The intimate, al fresco dinner party at ...
Nobel Prize winner Jennifer Doudna, who co-invented CRISPR-Cas9 genome editing technology, joined President Christina Paxson P’19 for a virtual conversation on CRISPR’s wide-ranging applications and ...
Nobel Prize–winning biochemist Dr. Jennifer Doudna is cracking the code of nature to address big issues, using the tiniest parts of us. On Tuesday, UCSB Arts & Lectures and the Cancer Foundation of ...
UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara co-present Dr. Jennifer Doudna, CRISPR Gene Editing and the Future of Human Health on Tuesday, Oct. 22, at 7:30 p.m. at The Granada ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...
With such striking effects, many scientists see modulating the microbiomes as a promising avenue for improving human health and wellbeing. In recent years, researchers have shown that tweaking the ...
Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream. CRISPR for high cholesterol ...
In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results